Products & Technology - Aquatic Health and Disease Control Products


	Company Description
	Our Team
	Board of Directors
	Scientific Advisory Board
	Investors

	Aquatic Health & Disease Control
	Aquafeeds Nutrition Platform
	Delivery Technologies Platform

	Aquaculture

	Press Releases
	ABN in the News
	Events

	General Contact Info
	Directions
	Contact Form

ABN is using the tools of modern molecular biology and genetics to develop solutions that will enable aquaculture to operate in a sustainable and economically viable fashion. This is critical as aquaculture expands to meet the world's growing needs for marine protein sources. In this manner, ABN is also enabling healthier products for human consumption by reducing aquaculture's prophylactic use of antibiotics in culturing systems.

Fish: Novel platform technology for oral vaccines

Shrimp: Solution to White Spot Virus

ABN is developing "ghost"
viruses that are effective
without being infective.

Fish

ABN is working under a Saltonstall-Kennedy grant to develop a novel platform technology for oral vaccines to combat fish diseases. The company's initial focus is on IPNV and ISA, diseases which cause considerable losses in the global salmon industry each year.

Shrimp

ABN is applying new tools of biotechnology to provide a solution to the White Spot Virus problem that has caused more than $1B in losses in the shrimp industry over the past three years.